Atlas Trials

Comparison of AVD + Low-Dose Nivolumab vs. PET-Adapted BEACOPP-like in Advanced cHL

Clinical trial NCT07234487 · RECRUITING

Trial details

NCT number
NCT07234487
Sponsor
St. Petersburg State Pavlov Medical University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Hodgkin Lymphoma
Start date
2024-10-14
Primary completion
2029-10-01
Enrollment
178

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.